Jan Voorberg

18PUBLICATIONS
85CO-AUTHORS
AutoimmunityHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oenology and viticulturePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 10, 2026
Unbiased plasma proteomics reveals hemolysis during ADAMTS13 relapse in patients with immune TTP.

|Dec 18, 2025
Allele-selective disruption of pathogenic VWF variants in type 2 von Willebrand disease using CRISPR/Cas9.

Isabel Bär, Stijn A Groten, Alastair Barraclough

|Aug 08, 2025
Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP.

Tim Postmus, Robin Jansen, Paul Kaijen

|Jan 17, 2025
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs.

Noa A Linthorst, Yvonne K Jongejan, Richard J Dirven

|Jan 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP.

Tim Postmus, Nelly Schilder, Juliana Ferreira de Santana

|Feb 26, 2024
Elevated levels of citrullinated fibrinogen in patients with cancer.

Tom Arfman, Valentina Zollet, Nick van Es

Pageof 3

Frequent Collaborators

8 joint publications

Ruben Bierings

4 joint publications

Tim Postmus

4 joint publications

Karen Vanhoorelbeke

4 joint publications

Frank W G Leebeek